Thorne Research launches TruCardia

Thorne Research launches TruCardia

Thorne has partnered with Mark Houston, MD, to launch venture providing novel nutritional supplements and education to support and promote cardiovascular health.

Thorne Research Inc., a leader in developing and manufacturing pure, high-quality nutritional supplements marketed through licensed health care practitioners, announced that the company has partnered with Mark Houston, MD, MS, M.Sc, and the Hypertension Institute to launch TruCardia®, a new venture providing novel nutritional supplements and educational programs to support and promote cardiovascular health. Dr. Houston will lead TruCardia’s efforts to develop a range of nutritional supplements and patient resources. Dr. Houston is the Director of the Hypertension Institute, one of the nation’s leading centers for cardiovascular health and a Cardiovascular Center of Excellence of the Consortium for Southeastern Hypertension Control, treating more than 20,000 patients each year.

The first product available from TruCardia is LipoCardia™, a nutritional supplement to help maintain healthy lipid levels. Three additional products will be launched in the first half of 2014: CardioPressin™, a nutritional supplement to support normal blood pressure levels, ArterioCare™, a nutritional supplement to support coronary artery blood flow and endothelial function to help maintain cardiovascular health, and MitoBio™, a nutritional supplement to help promote a healthier dynamic heart, enhance cardiac myocyte function, and promote mitochondrial biogenesis and function.

“Over 15 years of clinical research, experience, and clinical application have gone into the development of the TruCardia suite of nutritional supplements. Thorne Research, known for exceptional quality and purity, is a great partner in this endeavor,” said Dr. Houston.

The TruCardia nutritional supplement product line was developed using the most advanced research technologies available for the support of cardiovascular health. A combination of peer-reviewed medical and scientific literature, metabolomics-based composition and molecular pathway analysis, clinical research, and expert insight was used to determine the range of ingredients and dosing levels to achieve optimal efficacy of the TruCardia nutritional supplement line.

“Cardiovascular disease is the single leading cause of death globally. By educating patients about the prudent use of nutritional supplements, nutrition, effective tools to monitor their cardiovascular health, and choosing healthier lifestyle options, we can help them better manage their cardiovascular health. There is significant medical evidence indicating that nutritional supplements can positively impact cardiovascular health. TruCardia will offer the finest educational and nutritional resources to make a difference,” said Dr. Houston.

In addition to offering high-quality nutritional supplements, TruCardia will also support efforts in cardiovascular research and provide specialized physician and patient education programs in cardiovascular health.

“Thorne Research is proud to offer high-quality, evidence-based nutritional supplements to health-care providers to help them support the cardiovascular health of their patients. We are pleased to be working with Dr. Houston to develop new resources that will help patients take an active role in maintaining their cardiovascular health. TruCardia is another important milestone for Thorne Research as we continue to expand our product portfolio and support the efforts of healthcare providers to provide their patients with outstanding products backed by innovative programs in patient and clinician education,” said Paul Jacobson, CEO, Thorne Research.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.